Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Las Palmas GC
Clinical trial register · Spain

Clinical Trials in Las Palmas GC, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5881 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:19 UTC
5881
Studies in scope
all four open statuses
3099
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3244 Madrid 3050 Valencia 1215 Seville 1056 Málaga 750
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals11
Site location
Barcelona3244 Madrid3050 Valencia1215 Seville1056 Málaga750
All 453 locations
Target enrolment
to

Trials with a site in Las Palmas GC

11 of 5881 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Barcelona, Las Palmas GC, Madrid
2026-07-10
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Pozuelo de Alarcón, Barcelona, Las Palmas GC, Madrid, Seville
2026-06-03
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Barcelona, Las Palmas GC, Madrid
2026-05-27
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
648
Barcelona, Alicante, Córdoba, Las Palmas GC, Madrid, Valencia
2026-04-16
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Santiago Compostela, Huelva, El Palmar, Las Palmas GC, Madrid, Salamanca, Seville, Valencia
2025-10-03
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Badalona, Alicante, Granada, Las Palmas GC, Madrid, Pontevedra
2025-05-16
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Santiago Compostela, Pamplona, Castilleja de la Cuesta, A Coruña, Barcelona, Córdoba, Huelva, Las Palmas GC
2025-04-30
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Granada, Palma, Barcelona, Granollers, Las Palmas GC, Madrid, Pontevedra, Seville
2025-03-20
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Granada, Barcelona, Córdoba, Las Palmas GC, Valencia
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Barcelona, Alicante, Las Palmas GC, Madrid, Valencia
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 2
248
Granada, Sabadell, Manises, Barcelona, Las Palmas GC, Valencia
2019-02-27
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-spain/city/las-palmas-gc

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,881 studies in total at the last sync on 14 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Las Palmas GC.

How many clinical trials are recruiting in Las Palmas GC?

6 of the 11 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Las Palmas GC), 11 studies
PhaseStudiesRecruitingShare
Phase 39581.8%
Phase 22118.2%

Most active sponsors

Lead sponsors with the most studies (Las Palmas GC)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals116
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.